Skip to main content

Advertisement

SpringerLink
Log in

Inflammatory neuropathies

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

We discuss two of the most common of the acquired inflammatory neuropathies: Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy, as well as their variants. We review their clinical presentation, electrophysiologic findings, and management, highlighting knowledge gained from the recent literature. Unfortunately, although treatments exist for both Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy, none are completely curative and all have significant potential side effects and/ or expense. Better understanding of the underlying pathophysiology of these diseases is needed in order to develop more targeted therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Jacobs BC, Rothbarth PH, van der Meche N, et al.: The spectrum of antecedent infections in Guillain Barre syndrome. A casecontrol study. Neurology 1998, 51:1110–1115.

    PubMed  CAS  Google Scholar 

  2. Ogawara K, Kuwabara S, Mori, et al.: Axonal Guillain-Barre syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 2000, 48:624–631.

    Article  PubMed  CAS  Google Scholar 

  3. Brannagan TH 3rd, Zhou Y: HIV-associated Guillain-Barre syndrome. J Neurol Sci 2003, 208(1-2):39–42.

    Article  PubMed  Google Scholar 

  4. Wen PY, Alyea EP, Simon D, et al.: Guillain-Barre syndrome following allogeneic bone marrow transplantation. Neurology 1997, 49:1711–1714.

    PubMed  CAS  Google Scholar 

  5. Lasky T, Terracciano GJ, Magder L, et al.: The Guillain-Barre syndrome and the 1992–1993 and 1993–1994 influenza vaccines. N Engl J Med 1998, 339:1797–1802.

    Article  PubMed  CAS  Google Scholar 

  6. Pritchard J, Mukherjee R, Hughes RA: Risk of relapse of Guillain-Barre syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunization. J Neurol Neurosurg Psychiatry 2002, 73:348–349.

    Article  PubMed  CAS  Google Scholar 

  7. Wijdicks EF, Fletcher DD, Lawn ND: Influenza vaccine and the risk of relapse of Guillain-Barre syndrome. Neurology 2000, 55:452–453.

    PubMed  CAS  Google Scholar 

  8. Oh SJ, Kurokawa K, de Almeida DF, Ryan HF Jr, Claussen GC: Subacute inflammatory demyelinating polyneuropathy. Neurology 2003, 61:1507–1512.

    PubMed  CAS  Google Scholar 

  9. Rees JH, Thompson RD, Smeeton NC, Hughes RA: Epidemiological study of Guillain-Barre syndrome in south east England. J Neurol Neurosurg Psychiatry 1998, 64:74–77.

    Article  PubMed  CAS  Google Scholar 

  10. Fletcher DD, Lawn ND, Wolter TD, Wijdicks EF: Long-term outcome in patients with Guillain-Barre syndrome requiring mechanical ventilation. Neurology 2000, 54:2311–2315.

    PubMed  CAS  Google Scholar 

  11. Hiraga A, Mori M, Ogawara K, et al.: Differences in patterns of progression in demyelinating and axonal Guillain-Barre syndromes. Neurology 2003, 61:471–474.

    PubMed  CAS  Google Scholar 

  12. Kuwabara S, Asahina M, Mori M, et al.: Two patterns of clinical recovery in Guillain-Barre syndrome with anti-GM1 antibody. Neurology 1998, 51:1656–1660.

    PubMed  CAS  Google Scholar 

  13. Yuki N, Taki T, Inagaki F, et al.: A bacterium lipopolysaccaride that elicits Guillain-Barre syndrome has a GM1 gangliosidelike structure. J Exp Med 1993, 178:1771–1775.

    Article  PubMed  CAS  Google Scholar 

  14. Hafer-Macko CE, Sheikh KA, Li CY, et al.: Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 1996, 39:625–635.

    Article  PubMed  CAS  Google Scholar 

  15. Hafer-Macko CE, Hsieh ST, Li CY, et al.: Acute motor axonal neuropathy: an antibody mediated attack on axolemma. Ann Neurol 1996, 40:635–644.

    Article  PubMed  CAS  Google Scholar 

  16. Hughes RA, Wijdicks EF, Barohn R, et al.: Practice parameter: immunotherapy for Guillain-Barre syndrome. Report of the Quality of Standard Subcommittee of the American Academy of Neurology. Neurology 2003, 61:736–740. This is an excellent review of the published clinical trials of treatment in GBS with evidence-based recommendations for management of GBS patients.

    PubMed  CAS  Google Scholar 

  17. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group: Randomised trial of plasma exchange, intravenous immunoglobulin and combined treatments in Guillain-Barre syndrome. Lancet 1997, 349:225–230.

    Article  Google Scholar 

  18. van Koningsveld R, Schmitz PI, van der Meche FG, et al.: Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barre syndrome: randomized trial. Lancet 2004, 363:192–196.

    Article  PubMed  CAS  Google Scholar 

  19. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force: Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Adacemy of Neurology AIDS Task Force. Neurology 1991, 41:617–618.

    Google Scholar 

  20. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR: Chronic inflammatory demyelinating polyradiculoneuropathy: clinical characteristics, course and recommendations for diagnostic criteria. Arch Neurol 1989, 46:878–884.

    PubMed  CAS  Google Scholar 

  21. Schimdt B, Toyka KV, Kiefer R, et al.: Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 1996, 19:474–487.

    Article  Google Scholar 

  22. Kieseier BC, Dalakas MC, Hartung HP: Immune mechanisms in chronic inflammatory demyelinating neuropathy. Neurology 2002, 59(Suppl 6):S7-S12.

    PubMed  CAS  Google Scholar 

  23. Dyck PJ, O’Brien PC, Oviatt KF, et al.: Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 1982, 11:136–141.

    Article  PubMed  CAS  Google Scholar 

  24. Dyck PJ, Daube J, O’Brien P, et al.: Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 1986, 314:461–465.

    Article  PubMed  CAS  Google Scholar 

  25. Hahn AF, Bolton CF, Pillay N, et al.: Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy: a double-blind, sham-controlled, cross-over study. Brain 1996, 119:1055–1066.

    Article  PubMed  Google Scholar 

  26. Hahn AF, Bolton CF, Zochodne D, Feasby TE: Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebocontrolled, cross-over study. Brain 1996, 119:1067–1077.

    Article  PubMed  Google Scholar 

  27. Dyck PJ, Litchy WJ, Kratz KM, et al.: A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 1994, 36:838–845.

    Article  PubMed  CAS  Google Scholar 

  28. Mendell JR, Barohn RJ, Freimer ML, et al.: Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 2001, 56:445–449. This is a randomized controlled trial that demonstrated the efficacy of IVIg as first-line treatment in CIDP.

    PubMed  CAS  Google Scholar 

  29. Hughes R, Bensa S, Wilson H, et al.: Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001, 50:195–201.

    Article  PubMed  CAS  Google Scholar 

  30. Radziwill AJ, Steck AJ, Renaud S, Fuhr P: Distal motor latency and residual latency as sensitive markers of anti-MAG polyneuropathy. J Neurol 2003, 250:962–966.

    Article  PubMed  Google Scholar 

  31. Katz JS, Saperstein DS, Gronseth G, et al.: Distal acquired demyelinating symmetric neuropathy. Neurology 2000, 54:615–620. This is a retrospective review article that characterizes a distal variant of CIDP and describes its response to treatment.

    PubMed  CAS  Google Scholar 

  32. Saperstein DS, Katz JS, Amato AA, Barohn RJ: Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001, 24:311–324.

    Article  PubMed  CAS  Google Scholar 

  33. Gorson KC, Ropper AH, Weinberg DH, Weinstein R: Treatment experience in patients with anti-myelin-associated glycoprotein neuropathy. Muscle Nerve 2001, 24:778–786.

    Article  PubMed  CAS  Google Scholar 

  34. Dalakas MC, Quarles RH, Farrer RG, et al.: A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy. Ann Neurol 1996, 40:792–795.

    Article  PubMed  CAS  Google Scholar 

  35. Dyck PJ, Low PA, Windebank AJ, et al.: Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med 1991, 325:1482–1486.

    Article  PubMed  CAS  Google Scholar 

  36. Nobile-Orazio E, Meucci M, Baldini L, et al.: Long-term prognosis of neuropathy associated with anti-MAG IgM Mproteins and its relationship to immune therapies. Brain 2000, 123:710–717.

    Article  PubMed  Google Scholar 

  37. Saperstein DS, Amato AA, Wolfe GI, et al.: Multifocal acquired demyelinating sensory and motor neuropathy. The Lewis-Sumner syndrome. Muscle Nerve 1999, 22:560–566.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Brigham and Women’s Hospital, 75 Francis Street, 02115, Boston, MA, USA

    Anthony A. Amato MD

Authors
  1. Hannah R. Briemberg MD, FRCPC
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anthony A. Amato MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Briemberg, H.R., Amato, A.A. Inflammatory neuropathies. Curr Neurol Neurosci Rep 5, 66–71 (2005). https://doi.org/10.1007/s11910-005-0026-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-005-0026-z

Keywords

Search

Navigation